AI Article Synopsis
- Continuous phototherapy is more effective than intermittent light treatment for full-term newborns, particularly in cases of nonhemolytic hyperbilirubinemia with higher initial bilirubin levels.
- Treatment effectiveness improves with the infant's age, especially for those older than 3 days due to enhanced liver function.
- Shielding the liver area during phototherapy reduces treatment efficiency, indicating that the liver plays a role in the phototherapeutic process.
Article Abstract
Continuous phototherapy in full-term newborns was found to be more effective than intermittent illumination. Treatment efficacy was also related to age and the initial bilirubin level of the infants. In fact, the reported data indicate an increased therapeutic effect in newborns affected with nonhemolytic hyperbilirubinemia who had an initial bilirubin level greater than 15 mg/dl as compared to neonates with an initial bilirubin level less than 15 mg/dl. The light treatment was also more effective in infants older than 3 days, possibly because of an increased ligandin and conjugating capacity. Shielding the hepatic area during illumination significantly decreases the efficiency of this treatment, suggesting that the liver could also be a phototherapeutic action site.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!